tiprankstipranks
Rallybio (RLYB)
NASDAQ:RLYB
US Market

Rallybio (RLYB) Financial Statements

Compare
320 Followers

Rallybio Financial Overview

Rallybio's market cap is currently $27.24M. The company's EPS TTM is $-1.339; its P/E ratio is ―; Rallybio is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 636.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 636.00K$ -150.00K$ -167.00K$ -109.00K$ -62.03K
Operating Income$ -60.50M$ -78.93M$ -67.88M$ -45.65M$ -25.30M
EBITDA$ -60.50M$ -72.37M$ -65.41M$ -45.39M$ -24.83M
Net Income$ -57.77M$ -74.56M$ -66.49M$ -47.01M$ -24.93M
Balance Sheet
Cash & Short-Term Investments$ 65.51M$ 109.93M$ 168.99M$ 175.33M$ 140.23M
Total Assets$ 68.11M$ 115.62M$ 180.44M$ 182.19M$ 141.86M
Total Debt$ 154.00K$ 392.00K$ 555.00K$ 0.00$ 0.00
Net Debt$ -13.75M$ -24.10M$ -56.40M$ -175.33M$ -140.23M
Total Liabilities$ 6.45M$ 9.44M$ 11.12M$ 6.58M$ 187.88M
Stockholders' Equity$ 61.65M$ 106.18M$ 169.32M$ 175.60M$ -47.01M
Cash Flow
Free Cash Flow$ -49.28M$ -60.28M$ -57.34M$ -45.87M$ -22.18M
Operating Cash Flow$ -49.28M$ -60.27M$ -57.28M$ -45.53M$ -22.04M
Investing Cash Flow$ 33.49M$ 27.66M$ -112.17M$ -2.33M$ -2.07M
Financing Cash Flow$ 5.20M$ 143.00K$ 51.08M$ 82.97M$ 144.89M
Currency in USD

Rallybio Earnings and Revenue History

Rallybio Debt to Assets

Rallybio Cash Flow

Rallybio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis